Jun Hyo Sub, Ahn Jun Hyong, Kim Ji Hee, Oh Jae Keun, Song Joon Ho, Chang In Bok
Department of Neurosurgery, Hallym University Sacred Heart Hospital, Korea.
Department of Neurosurgery, Hallym University Sacred Heart Hospital, Korea
Interv Neuroradiol. 2016 Aug;22(4):407-12. doi: 10.1177/1591019916641314. Epub 2016 Apr 11.
The fate and safety of thrombus remnant despite intra-arterial thrombolysis for unexpected thrombus formation has rarely been reported.
From January 2010 to May 2015, 131 consecutive patients with ruptured intracranial aneurysms were treated by endovascular methods at our institution. Among the 21 patients (16%) treated by intra-arterial thrombolysis for the thrombus formation during the procedure, nine patients (nine aneurysms) suffered from thrombus remnant. We reviewed the clinical and radiologic outcomes of patients with thrombus remnant as well as intraoperative and postoperative management of thrombus formation.
Thrombus formation occurred near the coiled aneurysm in eight patients, and distal embolic occlusion was observed in one patient. All nine patients were initially managed by intra-arterial thrombolysis with tirofiban. One patient with persistent distal embolic occlusion and two patients with distal migration of the thrombus after intra-arterial thrombolysis were additionally treated with stent retriever. One patient with occlusion of the parent artery near the coiled aneurysm despite intra-arterial thrombolysis was partially recanalized by permanent deployment of a stent retriever. Delayed cerebral angiography showed no increase in size of thrombus remnant in any patients. After the procedure, thrombus remnant was managed by intravenous tirofiban. Follow-up CT angiography on the first postoperative day showed patent arterial flow, and ischemic complication related with thromboembolism did not occur in any patients. One patient suffered from hemorrhagic complication.
If the patency of parent artery is maintained and the size of the thrombus remnant does not increase on delayed angiography after intra-arterial thrombolysis, postoperative thromboembolic events rarely occur.
尽管采用动脉内溶栓治疗意外形成的血栓,但血栓残余物的转归及安全性鲜有报道。
2010年1月至2015年5月,我院采用血管内治疗方法连续治疗131例颅内动脉瘤破裂患者。在术中因血栓形成接受动脉内溶栓治疗的21例患者(16%)中,9例患者(9个动脉瘤)出现血栓残余。我们回顾了有血栓残余患者的临床和影像学结果以及血栓形成的术中及术后处理情况。
8例患者的血栓形成于弹簧圈栓塞的动脉瘤附近,1例患者出现远端栓塞性闭塞。所有9例患者最初均采用替罗非班动脉内溶栓治疗。1例持续存在远端栓塞性闭塞的患者以及2例动脉内溶栓后血栓远端迁移的患者接受了支架取栓器辅助治疗。1例尽管接受动脉内溶栓但弹簧圈栓塞的动脉瘤附近的载瘤动脉闭塞的患者通过永久性置入支架取栓器实现了部分再通。延迟脑血管造影显示,所有患者的血栓残余物大小均未增加。术后,血栓残余采用静脉注射替罗非班治疗。术后第1天的CT血管造影显示动脉血流通畅,所有患者均未发生与血栓栓塞相关的缺血性并发症。1例患者出现出血性并发症。
如果在动脉内溶栓后延迟血管造影时载瘤动脉保持通畅且血栓残余物大小不增加,术后很少发生血栓栓塞事件。